Inovio Pharmaceuticals, Inc. (NYSE MKT: INO)
Dr. Joseph Kim discusses with Equities.com discuses the potential of synthetic vaccines and immune therapies for cancers and infectious diseases.
This video interview may include forward-looking statements that involve risks and uncertainties. Forward- looking statements are statements that are not historical facts and are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. To read our full disclosure, please go to: http://www.equities.com/disclaimer.
- Brian Roberts, President of North...
- Published on 19 September 2013
- Views (615)
- Equities.com interviews Fred Thiel,...
- Published on 19 September 2014
- Views (97)
- Equities.com sits down with Manish...
- Published on 26 May 2013
- Views (559)